US and International Patents
1
1.
Isaac J. Powell and Navnath S. Gavande. “Compositions and methods related to inhibitors of pro-inflammatory factors for treatment of cancer” U.S. patent Application No. 63/213,871.
2.
John J. Turchi and Navnath Gavande. “Synthesis of heterocyclic Replication Protein A (RPA)-DNA interaction inhibitors treating cancers”. WO 2021/119242.
3.
Arun K Rishi and Navnath Gavande, “Compositions and methods for inhibiting CARP-1 binding to NEMO for treating cancer for enhancing the chemotherapeutic response” WO 2021/067572.
4.
John J. Turchi, Navnath Gavande, and Pamela S. VandeVere-Carozza, “Preparation of trisubstituted pyrazolin-5-ones as XPA-DNA interaction inhibitors for treatment of cancer”. WO 2019/060260.
5.
John J. Turchi, Navnath Gavande, and Pamela S. VandeVere-Carozza, “Preparation of aryl-pyrazone compounds as Ku inhibitors”. WO 2017/205503.
6.
David E. Hibbs, Noeris K. Salam, Tom H-W. Huang, Rebecca Roubin, Azadeh Martin, Navnath S. Gavande, Srinivas Nammi and Moon S. Kim, “Preparation of Benzopyran-4-one Derivatives as PPAR Agonists (Anti-diabetic agents)”; WO 2009/026657.
7.
David E. Hibbs, Noeris K. Salam, Rebecca Roubin, Azadeh Martin, Navnath S. Gavande, “Preparation of Diaryl Pyrazole Derivatives as PPAR Agonists (Anti-diabetic agents)”; WO 2009/026658.